BioCatalystWatch
DAREWorkspace / DARE / OverviewCompany library
Dare Bioscience, Inc. logo

Dare Bioscience, Inc.

Dare Bioscience, Inc. (DARE)

Website

Price
Market cap
Next catalystExpected 2026Ovaprene® — contraception studies · Enrollment completionSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

OvapreneOvaprene® — contraception studies

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Sildenafil Cream, 3.6%

PDE-5

PreINDP1P2FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

OvapreneOvaprene® — contraception studies

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Sildenafil Cream, 3.6%

PDE-5

PreINDP1P2FilingApproved
Upcoming / outlook

Other pipelines

DARE-HRT1

Upcoming / outlook

DARE-VVA1

Estrogen receptor

PreINDP1P2P3FilingApproved
DARE-PDM1

PreINDP1P2P3FilingApproved
DARE-IDDS

PreINDP1P2P3FilingApproved
CRLX101

Topoisomerase 1 × HIF-1α

PreINDP1P2P3FilingApproved

Partner / License out

Approved / commercial

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

DARE SEC archive